Showing results (111-120 of 201) with videos related to
Sort By:
Pageof 21
Biorxiv : the Preprint Server for Biology|August 23, 2023
Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.Gynecologic Oncology|March 16, 2022
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissuesLea A Moukarzel, Lorenzo Ferrando, Higinio Dopeso, et al.Gynecologic Oncology|November 1, 2025
A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancerSara Moufarrij, Claire F Friedman, Samuel Freeman, et al.Gynecologic Oncology Reports|August 4, 2021
Pattern of disease and response to pembrolizumab in recurrent cervical cancerKathryn M Miller, Olga T Filippova, Sara A Hayes, et al.Journal for Immunotherapy of Cancer|June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trialDmitriy Zamarin, Sven Walderich, Aliya Holland, et al.Nature Communications|January 9, 2025
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trialJyoti Mayadev, Dmitriy Zamarin, Wei Deng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2023
Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic TargetsClaire F Friedman, Vignesh Ravichandran, Kathryn Miller, et al.Cancer Discovery|May 13, 2022
Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian CancerChang-Suk Chae, Tito A Sandoval, Sung-Min Hwang, et al.Scientific Reports|October 21, 2020
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancersHarini Veeraraghavan, Claire F Friedman, Deborah F DeLair, et al.Journal for Immunotherapy of Cancer|October 24, 2020
Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patientsJean-Pascal Machiels, Carlos Gomez-Roca, Jean-Marie Michot, et al.Pageof 21